The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Summary

The objective of this study is to evaluate the safety and effectiveness of EVARREST™ Sealant Matrix (EVARREST™ Fibrin Sealant Patch) (EVARREST™) in controlling mild or moderate soft tissue \& parenchymal bleeding during open hepatic, abdominal, pelvic, retroperitoneal, and thoracic (non-cardiac) surgery in paediatric patients.

Timeline

Start

2014-07-01

Primary completion

2021-10-27

Completion

2021-11-12

Drugs

Indications